Binding of bacterial peptidoglycan to CD14.

Symbiotic bacteria direct expression of an intestinal bactericidal lectin. Science (2006) 9.95

A continuum of anionic charge: structures and functions of D-alanyl-teichoic acids in gram-positive bacteria. Microbiol Mol Biol Rev (2003) 5.18

The role of antimicrobial peptides in animal defenses. Proc Natl Acad Sci U S A (2000) 3.52

Recognition of Staphylococcus aureus by the innate immune system. Clin Microbiol Rev (2005) 2.50

Accessory molecules for Toll-like receptors and their function. Nat Rev Immunol (2012) 2.00

Role of Toll-like receptor 4 in gram-positive and gram-negative pneumonia in mice. Infect Immun (2004) 1.73

Modulation of release of proinflammatory bacterial compounds by antibacterials: potential impact on course of inflammation and outcome in sepsis and meningitis. Clin Microbiol Rev (2002) 1.61

Micrococci and peptidoglycan activate TLR2-->MyD88-->IRAK-->TRAF-->NIK-->IKK-->NF-kappaB signal transduction pathway that induces transcription of interleukin-8. Infect Immun (2001) 1.59

Staphylococcus aureus peptidoglycan is a toll-like receptor 2 activator: a reevaluation. Infect Immun (2005) 1.58

Peptidoglycan and lipoteichoic acid from Staphylococcus aureus induce tumor necrosis factor alpha, interleukin 6 (IL-6), and IL-10 production in both T cells and monocytes in a human whole blood model. Infect Immun (2000) 1.58

Structural basis for peptidoglycan binding by peptidoglycan recognition proteins. Proc Natl Acad Sci U S A (2004) 1.50

Interaction of cationic peptides with lipoteichoic acid and gram-positive bacteria. Infect Immun (1999) 1.40

Bacterial fimbriae and their peptides activate human gingival epithelial cells through Toll-like receptor 2. Infect Immun (2001) 1.21

Regulation of TLR2-mediated tolerance and cross-tolerance through IRAK4 modulation by miR-132 and miR-212. J Immunol (2012) 1.16

Membrane-associated proteins of a lipopolysaccharide-deficient mutant of Neisseria meningitidis activate the inflammatory response through toll-like receptor 2. Infect Immun (2001) 1.11

CD14-dependent and -independent cytokine and chemokine production by human THP-1 monocytes stimulated by Streptococcus suis capsular type 2. Clin Exp Immunol (2002) 1.11

Toll-like receptor 2- and MyD88-dependent phosphatidylinositol 3-kinase and Rac1 activation facilitates the phagocytosis of Listeria monocytogenes by murine macrophages. Infect Immun (2010) 1.09

Human lactoferrin interacts with soluble CD14 and inhibits expression of endothelial adhesion molecules, E-selectin and ICAM-1, induced by the CD14-lipopolysaccharide complex. Infect Immun (2000) 1.08

CD14 and toll-like receptor 4: a link between infection and acute coronary events? Heart (2004) 1.08

Transforming growth factor-beta inhibits lipopolysaccharide-stimulated expression of inflammatory cytokines in mouse macrophages through downregulation of activation protein 1 and CD14 receptor expression. Infect Immun (2000) 1.06

The crystal structure of human soluble CD14 reveals a bent solenoid with a hydrophobic amino-terminal pocket. J Immunol (2012) 0.97

TLR2-mediated cell stimulation in bacterial vaginosis. J Reprod Immunol (2007) 0.95

Soluble CD14 enhances membrane CD14-mediated responses to peptidoglycan: structural requirements differ from those for responses to lipopolysaccharide. Infect Immun (2000) 0.93

Interaction of human peripheral blood monocytes with apoptotic polymorphonuclear cells. Immunology (2009) 0.93

Recognition of Staphylococcus aureus-derived peptidoglycan (PGN) but not intact bacteria is mediated by CD14 in microglia. J Neuroimmunol (2005) 0.92

Recognition of pathogenic microbes by the Drosophila phagocytic pattern recognition receptor Eater. J Biol Chem (2011) 0.92

Dietary glycine prevents peptidoglycan polysaccharide-induced reactive arthritis in the rat: role for glycine-gated chloride channel. Infect Immun (2001) 0.90

Adjuvant TACE inhibitor treatment improves the outcome of TLR2-/- mice with experimental pneumococcal meningitis. BMC Infect Dis (2007) 0.89

The synthetic immunomodulator murabutide controls human immunodeficiency virus type 1 replication at multiple levels in macrophages and dendritic cells. J Virol (2000) 0.89

A phosphatidylserine species inhibits a range of TLR- but not IL-1beta-induced inflammatory responses by disruption of membrane microdomains. J Immunol (2008) 0.88

Teichoic acids are not required for Streptococcus pneumoniae and Staphylococcus aureus cell walls to trigger the release of tumor necrosis factor by peripheral blood monocytes. Infect Immun (2003) 0.87

Soluble CD14 and CD83 from human neonatal antigen-presenting cells are inducible by commensal bacteria and suppress allergen-induced human neonatal Th2 differentiation. Infect Immun (2007) 0.87

Interaction of the HIV-1 gp120 viral protein V3 loop with bacterial lipopolysaccharide: a pattern recognition inhibition. J Biol Chem (2011) 0.86

PROTECTIVE EFFECTS OF HUMAN AND MOUSE SOLUBLE SCAVENGER-LIKE CD6 LYMPHOCYTE RECEPTOR IN A LETHAL MODEL OF POLYMICROBIAL SEPSIS. Antimicrob Agents Chemother (2016) 0.85

CD14 mediates the innate immune responses to arthritopathogenic peptidoglycan-polysaccharide complexes of Gram-positive bacterial cell walls. Arthritis Res Ther (2004) 0.83

Antiviral treatment with alpha interferon up-regulates CD14 on liver macrophages and its soluble form in patients with chronic hepatitis B. Antimicrob Agents Chemother (2005) 0.82

Evolving Bacterial Envelopes and Plasticity of TLR2-Dependent Responses: Basic Research and Translational Opportunities. Front Immunol (2013) 0.81

Enzyme degradation and proinflammatory activity in arthritogenic and nonarthritogenic Eubacterium aerofaciens cell walls. Infect Immun (2001) 0.81

Acute respiratory distress syndrome in the septic surgical patient. World J Surg (2003) 0.81

Heparin and enoxaparin enhance endotoxin-induced tumor necrosis factor-alpha production in human monocytes. Ann Surg (1999) 0.79

The involvement of CD14 in the activation of human monocytes by peptidoglycan monomers. Mediators Inflamm (2001) 0.78

Solution NMR studies provide structural basis for endotoxin pattern recognition by the innate immune receptor CD14. Biochem Biophys Res Commun (2008) 0.78

Therapeutic Developments Targeting Toll-like Receptor-4-Mediated Neuroinflammation. ChemMedChem (2015) 0.77

Divergent responses to peptidoglycans derived from different E. coli serotypes influence inflammatory outcome in trout, Oncorhynchus mykiss, macrophages. BMC Genomics (2011) 0.76

Herpesviral infection and Toll-like receptor 2. Protein Cell (2012) 0.76

Extending Immunological Profiling in the Gilthead Sea Bream, Sparus aurata, by Enriched cDNA Library Analysis, Microarray Design and Initial Studies upon the Inflammatory Response to PAMPs. Int J Mol Sci (2017) 0.75

Construction and expression of a novel anti-CD14 human-mouse chimeric antibody Hm2F9. DNA Cell Biol (2014) 0.75

Static magnetic field attenuates lipopolysaccharide-induced inflammation in pulp cells by affecting cell membrane stability. ScientificWorldJournal (2015) 0.75

CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science (1990) 17.86

Structure and function of lipopolysaccharide binding protein. Science (1990) 7.76

Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin. Annu Rev Immunol (1995) 6.99

BMK1/ERK5 regulates serum-induced early gene expression through transcription factor MEF2C. EMBO J (1997) 4.51

Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14. Proc Natl Acad Sci U S A (1993) 4.35

Leptospiral lipopolysaccharide activates cells through a TLR2-dependent mechanism. Nat Immunol (2001) 4.13

Isolation of a lipopolysaccharide-binding acute phase reactant from rabbit serum. J Exp Med (1986) 3.84

CD14 is a pattern recognition receptor. Immunity (1994) 3.79

Lipopolysaccharide is in close proximity to each of the proteins in its membrane receptor complex. transfer from CD14 to TLR4 and MD-2. J Biol Chem (2001) 2.94

Recognition of gram-negative bacteria and endotoxin by the innate immune system. Curr Opin Immunol (1999) 2.85

Lipopolysaccharide (LPS) binding protein opsonizes LPS-bearing particles for recognition by a novel receptor on macrophages. J Exp Med (1989) 2.72

Bmk1/Erk5 is required for cell proliferation induced by epidermal growth factor. Nature (1998) 2.62

Toll-like receptor 4, but not toll-like receptor 2, is a signaling receptor for Escherichia and Salmonella lipopolysaccharides. J Immunol (2000) 2.16

Adaptation to bacterial lipopolysaccharide controls lipopolysaccharide-induced tumor necrosis factor production in rabbit macrophages. J Clin Invest (1990) 2.12

Transfection of CD14 into 70Z/3 cells dramatically enhances the sensitivity to complexes of lipopolysaccharide (LPS) and LPS binding protein. J Exp Med (1992) 2.05

Endotoxin induces rapid protein tyrosine phosphorylation in 70Z/3 cells expressing CD14. J Biol Chem (1993) 1.93

MD-2 binds to bacterial lipopolysaccharide. J Biol Chem (2001) 1.91

Control of lipopolysaccharide (LPS) binding and LPS-induced tumor necrosis factor secretion in human peripheral blood monocytes. J Immunol (1992) 1.82

Recognition of endotoxin by cells leading to transmembrane signaling. Curr Opin Immunol (1994) 1.67

Plasma lipopolysaccharide (LPS)-binding protein. A key component in macrophage recognition of gram-negative LPS. J Immunol (1992) 1.66

Big mitogen-activated kinase regulates multiple members of the MEF2 protein family. J Biol Chem (2000) 1.57

Glycosyl-phosphatidylinositol-anchored or integral membrane forms of CD14 mediate identical cellular responses to endotoxin. Proc Natl Acad Sci U S A (1993) 1.55

Lipopolysaccharide (LPS) signal transduction and clearance. Dual roles for LPS binding protein and membrane CD14. J Biol Chem (1995) 1.54

Lipopolysaccharide binding protein enhances the responsiveness of alveolar macrophages to bacterial lipopolysaccharide. Implications for cytokine production in normal and injured lungs. J Clin Invest (1992) 1.48

MEKK3 directly regulates MEK5 activity as part of the big mitogen-activated protein kinase 1 (BMK1) signaling pathway. J Biol Chem (1999) 1.47

Control of lipopolysaccharide-high density lipoprotein binding by acute phase protein(s). J Immunol (1983) 1.42

Birefringence of muscle proteins and the problem of structural birefringence. Biochim Biophys Acta (1968) 1.35

Identification of lipopolysaccharide-binding proteins in 70Z/3 cells by photoaffinity cross-linking. J Biol Chem (1990) 1.33

CD14 receptor-mediated uptake of nonopsonized Mycobacterium tuberculosis by human microglia. Infect Immun (1995) 1.33

Analysis of lipopolysaccharide binding by CD14. J Biol Chem (1993) 1.29

Control of lipopolysaccharide-high-density lipoprotein interactions by an acute-phase reactant in human serum. Infect Immun (1985) 1.27

Lipopolysaccharide (LPS)-binding protein in human serum determines the tumor necrosis factor response of monocytes to LPS. J Infect Dis (1994) 1.26

Lactoferrin inhibits the endotoxin interaction with CD14 by competition with the lipopolysaccharide-binding protein. Infect Immun (1998) 1.25

BMK1 mediates growth factor-induced cell proliferation through direct cellular activation of serum and glucocorticoid-inducible kinase. J Biol Chem (2001) 1.19

Endotoxin interactions with lipopolysaccharide-responsive cells. Clin Infect Dis (1999) 1.18

Interactions of bacterial lipopolysaccharide with acute-phase rabbit serum and isolation of two forms of rabbit serum amyloid A. J Immunol (1982) 1.17

Enhancement of murine macrophage binding of and response to bacterial lipopolysaccharide (LPS) by LPS-binding protein. J Leukoc Biol (1992) 1.16

A critical role for monocytes and CD14 in endotoxin-induced endothelial cell activation. J Exp Med (1993) 1.12

Cellular binding of soluble CD14 requires lipopolysaccharide (LPS) and LPS-binding protein. J Biol Chem (1997) 1.06

Lipopolysaccharide binding protein and CD14 modulate the synthesis of platelet-activating factor by human monocytes and mesangial and endothelial cells stimulated with lipopolysaccharide. J Immunol (1995) 1.05

Lipopolysaccharide (LPS)-binding protein and soluble CD14 function as accessory molecules for LPS-induced changes in endothelial barrier function, in vitro. J Clin Invest (1994) 1.05

Lipopolysaccharide binding protein expression in primary human hepatocytes and HepG2 hepatoma cells. J Biol Chem (1994) 1.05

Purification and characterization of murine lipopolysaccharide-binding protein. Infect Immun (1993) 1.05

Phagocytosis of gram-negative bacteria by a unique CD14-dependent mechanism. J Leukoc Biol (1997) 1.04

Soluble CD14-mediated cellular responses to lipopolysaccharide. Chem Immunol (2000) 1.01

Structure-function analysis of CD14 as a soluble receptor for lipopolysaccharide. J Biol Chem (2000) 1.01

Biosynthesis of lipopolysaccharide-binding protein in rabbit hepatocytes. Pathobiology (1990) 0.99

Cell activation mediated by glycosylphosphatidylinositol-anchored or transmembrane forms of CD14. Infect Immun (1998) 0.97

The CD14 differentiation antigen mediates the development of endotoxin responsiveness during differentiation of mononuclear phagocytes. J Leukoc Biol (1994) 0.95

Interactions of lipopolysaccharide with neutrophils in blood via CD14. J Leukoc Biol (1993) 0.95

Role of BMK1 in regulation of growth factor-induced cellular responses. Immunol Res (2000) 0.94

Structural determinants for the interaction of lipopolysaccharide binding protein with purified high density lipoproteins: role of apolipoprotein A-I. J Lipid Res (1997) 0.94

Asthma and endotoxin: lipopolysaccharide-binding protein and soluble CD14 in bronchoalveolar compartment. Am J Physiol (1996) 0.94

Soluble CD14 enhances membrane CD14-mediated responses to peptidoglycan: structural requirements differ from those for responses to lipopolysaccharide. Infect Immun (2000) 0.93

The toll of Toll-like receptors, especially toll-like receptor 2, on murine atherosclerosis. Curr Drug Targets (2007) 0.93

Neutrophil adherence induced by lipopolysaccharide in vitro. Role of plasma component interaction with lipopolysaccharide. J Clin Invest (1992) 0.93

Regulated expression of a mammalian nonsense suppressor tRNA gene in vivo and in vitro using the lac operator/repressor system. Mol Cell Biol (1992) 0.88

Lipopolysaccharide (LPS) binding protein, truncated at Ile-197, binds LPS but does not transfer LPS to CD14. J Biol Chem (1994) 0.87

Lipopolysaccharide binding protein in acute pancreatitis. Crit Care Med (2000) 0.87

A new model of macrophage stimulation by bacterial lipopolysaccharide. J Trauma (1990) 0.87

Endotoxin, endotoxin-binding protein, and soluble CD14 are present in bronchoalveolar lavage fluid of patients with adult respiratory distress syndrome. Chest (1994) 0.86

Roles for LBP and soluble CD14 in cellular uptake of LPS. Prog Clin Biol Res (1998) 0.83

Activation of endothelial cells by endotoxin: direct versus indirect pathways and the role of CD14. Prog Clin Biol Res (1995) 0.83

Tumor necrosis factor-alpha and interleukin-1 beta mediate human endothelial cell activation in blood at low endotoxin concentrations. J Inflamm (1995) 0.82

Regulation of the host response to bacterial lipopolysaccharides. Fed Proc (1984) 0.82

Interactions of bacterial lipopolysaccharides with serum proteins. Prog Clin Biol Res (1988) 0.82

Lipopolysaccharide-binding proteins of Limulus amebocyte lysate. Infect Immun (1993) 0.80

Observation of two procrosins in extracts of human spermatozoa. Biochem Biophys Res Commun (1977) 0.79

Fluorescence resonance energy transfer analysis of lipopolysaccharide in detergent micelles. Biophys J (1996) 0.79

Membrane-anchored forms of lipopolysaccharide (LPS)-binding protein do not mediate cellular responses to LPS independently of CD14. J Immunol (1999) 0.78

The extraction of acrosin from human spermatozoa. Biol Reprod (1976) 0.76

Bath exposure of Atlantic halibut (Hippoglossus hippoglossus L.) yolk sac larvae to bacterial lipopolysaccharide (LPS): absorption and distribution of the LPS and effect on fish survival. Fish Shellfish Immunol (2000) 0.75

Isolation, partial characterization, and concentration in experimental sepsis of baboon lipopolysaccharide-binding protein. J Lab Clin Med (2000) 0.75